HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$5.04
Day range
$4.60 - $5.05
Year range
$4.60 - $16.77
Market cap
277.89M USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 37.62M | 61.17% |
Net income | -34.56M | -60.71% |
Net profit margin | — | — |
Earnings per share | -0.60 | -25.00% |
EBITDA | -37.53M | -61.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 214.76M | -22.44% |
Total assets | 230.17M | -21.39% |
Total liabilities | 31.26M | 76.97% |
Total equity | 198.91M | — |
Shares outstanding | 57.26M | — |
Price to book | 1.45 | — |
Return on assets | -38.81% | — |
Return on capital | -43.77% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -34.56M | -60.71% |
Cash from operations | -27.02M | -18.78% |
Cash from investing | 45.92M | 280.53% |
Cash from financing | 92.00K | -99.93% |
Net change in cash | 19.00M | -76.96% |
Free cash flow | -13.81M | -32.44% |
About
Founded
2006
Headquarters
Website
Employees
88
